We are live on ! Find out more
XBIT icon

XBiotech
XBIT

46 hedge funds and large institutions have $58.4M invested in XBiotech in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 2

700% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 2

383% more capital invested

Capital invested by funds: $12.1M → $58.4M (+$46.3M)

44% more funds holding

Funds holding: 32 → 46 (+14)

Holders
46
Holders Change
+14
Holders Change %
+43.75%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$5.1M
2
State Street
State Street
Massachusetts
+$2.98M
3
Northern Trust
Northern Trust
Illinois
+$2.11M
4
BIT
BlackRock Institutional Trust
California
+$1.94M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.52M

Top Sellers

Rank Fund Capital Flow
1
AA
ALPS Advisors
Colorado
-$342K
2
GCP
GSA Capital Partners
United Kingdom
-$162K
3
Citigroup
Citigroup
New York
-$24.3K
4
TRCT
Tower Research Capital (TRC)
New York
-$18.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$18.2M +$5.1M +353,253 +68%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.5M +$1.52M +105,511 +27%
State Street
3
State Street
Massachusetts
$5.16M +$2.98M +206,318 +509%
Northern Trust
4
Northern Trust
Illinois
$4M +$2.11M +146,442 +328%
BIT
5
BlackRock Institutional Trust
California
$3.53M +$1.94M +134,692 +396%
BIM
6
BlackRock Investment Management
Delaware
$1.4M +$763K +52,881 +372%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.27M +$284K +19,661 +48%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$1.21M +$648K +44,902 +342%
IG
9
ING Group
Netherlands
$1.12M +$774K +53,611 New
Goldman Sachs
10
Goldman Sachs
New York
$1.09M +$754K +52,248 New
TCIM
11
TIAA CREF Investment Management
New York
$1M +$510K +35,331 +281%
Deutsche Bank
12
Deutsche Bank
Germany
$903K +$512K +35,510 +457%
California State Teachers Retirement System (CalSTRS)
13
California State Teachers Retirement System (CalSTRS)
California
$767K +$405K +28,029 +324%
Charles Schwab
14
Charles Schwab
California
$761K +$317K +21,994 +153%
Swiss National Bank
15
Swiss National Bank
Switzerland
$718K +$495K +34,300 New
UBS Group
16
UBS Group
Switzerland
$623K +$430K +29,779 New
ProShare Advisors
17
ProShare Advisors
Maryland
$549K +$27.6K +1,909 +8%
TA
18
Teachers Advisors
New York
$541K +$291K +20,159 +354%
MHS
19
M Holdings Securities
Oregon
$540K – – –
CS
20
Credit Suisse
Switzerland
$385K +$266K +18,413 New
DekaBank Deutsche Girozentrale
21
DekaBank Deutsche Girozentrale
Germany
$376K +$57.7K +4,000 +29%
SO
22
STRS Ohio
Ohio
$376K +$241K +16,700 +1,285%
SF
23
Synovus Financial
Georgia
$370K – – –
AllianceBernstein
24
AllianceBernstein
Tennessee
$362K +$250K +17,300 New
Morgan Stanley
25
Morgan Stanley
New York
$336K +$81.2K +5,627 +54%
1
2

XBIT Hedge Fund Activity: Q2 2016 in Review

46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2016, worth a combined $58.4M — up 383% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new XBIT positions and 2 closed out — a net gain of 14 holders — while 24 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.1M. The largest seller was ALPS Advisors, exiting entirely with an estimated $342K sold.

  • 46 institutional investors held XBiotech (XBIT) as of Q2 2016, up from 32 in Q1 2016.
  • Funds reported $58.4M of XBiotech stock for Q2 2016, up 383% quarter-over-quarter.
  • 16 funds opened new XBiotech positions in Q2 2016 and 2 closed out, a net change of +14 holders.
  • The largest XBiotech buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $5.1M added.
  • The largest XBiotech seller in Q2 2016 was ALPS Advisors, an estimated $342K sold.

Based on aggregated 13F filings for Q2 2016.